Hotline: +86-18022463983    020-85206863

Global Microbial CDMO Service Market Research Report 2026

Published Date: 2026-04-07   |   Pages: 109   |   Tables: 107   |  Medical Care

The global Microbial CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Microbial CDMO Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Microbial CDMO Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Microbial CDMO Service in SMBs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Microbial CDMO Service include Lonza, AGC Biologics, FUJIFILM Diosynth Biotechnologies, Laurus Bio, BOC Sciences, AbbVie, Cytovance Biologics, ADL Biopharma, EUROAPI, KBI Biopharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Microbial CDMO Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microbial CDMO Service. The Microbial CDMO Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Microbial CDMO Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microbial CDMO Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Lonza
AGC Biologics
FUJIFILM Diosynth Biotechnologies
Laurus Bio
BOC Sciences
AbbVie
Cytovance Biologics
ADL Biopharma
EUROAPI
KBI Biopharma
Segment by Type
Fermentation Scale-Up
cGMP Manufacturing
Other
Segment by Application
SMBs
Large Companies
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Microbial CDMO Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbial CDMO Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Fermentation Scale-Up
1.2.3 cGMP Manufacturing
1.2.4 Other
1.3 Market by Application
1.3.1 Global Microbial CDMO Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbial CDMO Service Market Perspective (2021–2032)
2.2 Global Microbial CDMO Service Growth Trends by Region
2.2.1 Global Microbial CDMO Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Microbial CDMO Service Historic Market Size by Region (2021–2026)
2.2.3 Microbial CDMO Service Forecasted Market Size by Region (2027–2032)
2.3 Microbial CDMO Service Market Dynamics
2.3.1 Microbial CDMO Service Industry Trends
2.3.2 Microbial CDMO Service Market Drivers
2.3.3 Microbial CDMO Service Market Challenges
2.3.4 Microbial CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbial CDMO Service Players by Revenue
3.1.1 Global Top Microbial CDMO Service Players by Revenue (2021–2026)
3.1.2 Global Microbial CDMO Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Microbial CDMO Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Microbial CDMO Service Revenue
3.4 Global Microbial CDMO Service Market Concentration Ratio
3.4.1 Global Microbial CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbial CDMO Service Revenue in 2025
3.5 Global Key Players of Microbial CDMO Service Head Offices and Areas Served
3.6 Global Key Players of Microbial CDMO Service, Products and Applications
3.7 Global Key Players of Microbial CDMO Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Microbial CDMO Service Breakdown Data by Type
4.1 Global Microbial CDMO Service Historic Market Size by Type (2021–2026)
4.2 Global Microbial CDMO Service Forecasted Market Size by Type (2027–2032)
5 Microbial CDMO Service Breakdown Data by Application
5.1 Global Microbial CDMO Service Historic Market Size by Application (2021–2026)
5.2 Global Microbial CDMO Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Microbial CDMO Service Market Size (2021–2032)
6.2 North America Microbial CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Microbial CDMO Service Market Size by Country (2021–2026)
6.4 North America Microbial CDMO Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbial CDMO Service Market Size (2021–2032)
7.2 Europe Microbial CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Microbial CDMO Service Market Size by Country (2021–2026)
7.4 Europe Microbial CDMO Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Microbial CDMO Service Market Size (2021–2032)
8.2 Asia-Pacific Microbial CDMO Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Microbial CDMO Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Microbial CDMO Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Microbial CDMO Service Market Size (2021–2032)
9.2 Latin America Microbial CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Microbial CDMO Service Market Size by Country (2021–2026)
9.4 Latin America Microbial CDMO Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbial CDMO Service Market Size (2021–2032)
10.2 Middle East & Africa Microbial CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Microbial CDMO Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Microbial CDMO Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Microbial CDMO Service Introduction
11.1.4 Lonza Revenue in Microbial CDMO Service Business (2021–2026)
11.1.5 Lonza Recent Development
11.2 AGC Biologics
11.2.1 AGC Biologics Company Details
11.2.2 AGC Biologics Business Overview
11.2.3 AGC Biologics Microbial CDMO Service Introduction
11.2.4 AGC Biologics Revenue in Microbial CDMO Service Business (2021–2026)
11.2.5 AGC Biologics Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Microbial CDMO Service Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Microbial CDMO Service Business (2021–2026)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 Laurus Bio
11.4.1 Laurus Bio Company Details
11.4.2 Laurus Bio Business Overview
11.4.3 Laurus Bio Microbial CDMO Service Introduction
11.4.4 Laurus Bio Revenue in Microbial CDMO Service Business (2021–2026)
11.4.5 Laurus Bio Recent Development
11.5 BOC Sciences
11.5.1 BOC Sciences Company Details
11.5.2 BOC Sciences Business Overview
11.5.3 BOC Sciences Microbial CDMO Service Introduction
11.5.4 BOC Sciences Revenue in Microbial CDMO Service Business (2021–2026)
11.5.5 BOC Sciences Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Microbial CDMO Service Introduction
11.6.4 AbbVie Revenue in Microbial CDMO Service Business (2021–2026)
11.6.5 AbbVie Recent Development
11.7 Cytovance Biologics
11.7.1 Cytovance Biologics Company Details
11.7.2 Cytovance Biologics Business Overview
11.7.3 Cytovance Biologics Microbial CDMO Service Introduction
11.7.4 Cytovance Biologics Revenue in Microbial CDMO Service Business (2021–2026)
11.7.5 Cytovance Biologics Recent Development
11.8 ADL Biopharma
11.8.1 ADL Biopharma Company Details
11.8.2 ADL Biopharma Business Overview
11.8.3 ADL Biopharma Microbial CDMO Service Introduction
11.8.4 ADL Biopharma Revenue in Microbial CDMO Service Business (2021–2026)
11.8.5 ADL Biopharma Recent Development
11.9 EUROAPI
11.9.1 EUROAPI Company Details
11.9.2 EUROAPI Business Overview
11.9.3 EUROAPI Microbial CDMO Service Introduction
11.9.4 EUROAPI Revenue in Microbial CDMO Service Business (2021–2026)
11.9.5 EUROAPI Recent Development
11.10 KBI Biopharma
11.10.1 KBI Biopharma Company Details
11.10.2 KBI Biopharma Business Overview
11.10.3 KBI Biopharma Microbial CDMO Service Introduction
11.10.4 KBI Biopharma Revenue in Microbial CDMO Service Business (2021–2026)
11.10.5 KBI Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Microbial CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Fermentation Scale-Up
Table 3. Key Players of cGMP Manufacturing
Table 4. Key Players of Other
Table 5. Global Microbial CDMO Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Microbial CDMO Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Microbial CDMO Service Market Size by Region (US$ Million), 2021–2026
Table 8. Global Microbial CDMO Service Market Share by Region (2021–2026)
Table 9. Global Microbial CDMO Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Microbial CDMO Service Market Share by Region (2027–2032)
Table 11. Microbial CDMO Service Market Trends
Table 12. Microbial CDMO Service Market Drivers
Table 13. Microbial CDMO Service Market Challenges
Table 14. Microbial CDMO Service Market Restraints
Table 15. Global Microbial CDMO Service Revenue by Players (US$ Million), 2021–2026
Table 16. Global Microbial CDMO Service Market Share by Players (2021–2026)
Table 17. Global Top Microbial CDMO Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microbial CDMO Service Revenue, 2025
Table 18. Ranking of Global Top Microbial CDMO Service Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Microbial CDMO Service Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Microbial CDMO Service, Headquarters and Area Served
Table 21. Global Key Players of Microbial CDMO Service, Products and Applications
Table 22. Global Key Players of Microbial CDMO Service, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Microbial CDMO Service Market Size by Type (US$ Million), 2021–2026
Table 25. Global Microbial CDMO Service Revenue Market Share by Type (2021–2026)
Table 26. Global Microbial CDMO Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Microbial CDMO Service Revenue Market Share by Type (2027–2032)
Table 28. Global Microbial CDMO Service Market Size by Application (US$ Million), 2021–2026
Table 29. Global Microbial CDMO Service Revenue Market Share by Application (2021–2026)
Table 30. Global Microbial CDMO Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Microbial CDMO Service Revenue Market Share by Application (2027–2032)
Table 32. North America Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Microbial CDMO Service Market Size by Country (US$ Million), 2021–2026
Table 34. North America Microbial CDMO Service Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Microbial CDMO Service Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Microbial CDMO Service Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Microbial CDMO Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Microbial CDMO Service Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Microbial CDMO Service Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Microbial CDMO Service Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Microbial CDMO Service Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Microbial CDMO Service Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Microbial CDMO Service Market Size by Country (US$ Million), 2027–2032
Table 47. Lonza Company Details
Table 48. Lonza Business Overview
Table 49. Lonza Microbial CDMO Service Product
Table 50. Lonza Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 51. Lonza Recent Development
Table 52. AGC Biologics Company Details
Table 53. AGC Biologics Business Overview
Table 54. AGC Biologics Microbial CDMO Service Product
Table 55. AGC Biologics Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 56. AGC Biologics Recent Development
Table 57. FUJIFILM Diosynth Biotechnologies Company Details
Table 58. FUJIFILM Diosynth Biotechnologies Business Overview
Table 59. FUJIFILM Diosynth Biotechnologies Microbial CDMO Service Product
Table 60. FUJIFILM Diosynth Biotechnologies Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 61. FUJIFILM Diosynth Biotechnologies Recent Development
Table 62. Laurus Bio Company Details
Table 63. Laurus Bio Business Overview
Table 64. Laurus Bio Microbial CDMO Service Product
Table 65. Laurus Bio Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 66. Laurus Bio Recent Development
Table 67. BOC Sciences Company Details
Table 68. BOC Sciences Business Overview
Table 69. BOC Sciences Microbial CDMO Service Product
Table 70. BOC Sciences Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 71. BOC Sciences Recent Development
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Microbial CDMO Service Product
Table 75. AbbVie Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 76. AbbVie Recent Development
Table 77. Cytovance Biologics Company Details
Table 78. Cytovance Biologics Business Overview
Table 79. Cytovance Biologics Microbial CDMO Service Product
Table 80. Cytovance Biologics Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 81. Cytovance Biologics Recent Development
Table 82. ADL Biopharma Company Details
Table 83. ADL Biopharma Business Overview
Table 84. ADL Biopharma Microbial CDMO Service Product
Table 85. ADL Biopharma Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 86. ADL Biopharma Recent Development
Table 87. EUROAPI Company Details
Table 88. EUROAPI Business Overview
Table 89. EUROAPI Microbial CDMO Service Product
Table 90. EUROAPI Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 91. EUROAPI Recent Development
Table 92. KBI Biopharma Company Details
Table 93. KBI Biopharma Business Overview
Table 94. KBI Biopharma Microbial CDMO Service Product
Table 95. KBI Biopharma Revenue in Microbial CDMO Service Business (US$ Million), 2021–2026
Table 96. KBI Biopharma Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report


List of Figures
Figure 1. Microbial CDMO Service Picture
Figure 2. Global Microbial CDMO Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Microbial CDMO Service Market Share by Type: 2025 vs 2032
Figure 4. Fermentation Scale-Up Features
Figure 5. cGMP Manufacturing Features
Figure 6. Other Features
Figure 7. Global Microbial CDMO Service Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Microbial CDMO Service Market Share by Application: 2025 vs 2032
Figure 9. SMBs Case Studies
Figure 10. Large Companies Case Studies
Figure 11. Microbial CDMO Service Report Years Considered
Figure 12. Global Microbial CDMO Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Microbial CDMO Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Microbial CDMO Service Market Share by Region: 2025 vs 2032
Figure 15. Global Microbial CDMO Service Market Share by Players in 2025
Figure 16. Global Microbial CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Microbial CDMO Service Revenue in 2025
Figure 18. North America Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Microbial CDMO Service Market Share by Country (2021–2032)
Figure 20. United States Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Microbial CDMO Service Market Share by Country (2021–2032)
Figure 24. Germany Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Microbial CDMO Service Market Share by Region (2021–2032)
Figure 32. China Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Microbial CDMO Service Market Share by Country (2021–2032)
Figure 40. Mexico Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Microbial CDMO Service Market Share by Country (2021–2032)
Figure 44. Israel Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Microbial CDMO Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Lonza Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 48. AGC Biologics Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 49. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 50. Laurus Bio Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 51. BOC Sciences Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 52. AbbVie Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 53. Cytovance Biologics Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 54. ADL Biopharma Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 55. EUROAPI Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 56. KBI Biopharma Revenue Growth Rate in Microbial CDMO Service Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Our Clients